News
An orexin receptor agonist designed to address orexin deficiency in adults with narcolepsy type 1 is launching globally, with US availability expected shortly.
Read More
The artificial intelligence-based software as a medical device uses existing pulse oximetry signals to estimate sleep duration and will be integrated into a specific home sleep testing diagnostic solution.
Read More
The board of directors has appointed a new chief executive officer to succeed the current leader, effective at the start of the new year, to support upcoming growth objectives.
Read More
How clinicians can navigate the differential diagnosis.
Read More
The agency’s new program aims to reduce hospital readmissions by accelerating access to home-based medical technologies, including several targeting sleep.
Read More
New research reveals that popular artificial intelligence models often abandon medical referral advice when patients downplay their symptoms.
Read More
The newly cleared device allows clinicians to record multi-day and multi-night EEG data in a patient's home for sleep and neurophysiological care.
Read More
Built with PVDF technology, GentleTouch patches provide thoracic or abdominal effort waveforms without a belt.
Read More
A new study suggests that tracking daytime naps with wrist-worn actigraphy could provide a practical measure of symptom burden and treatment response in narcolepsy type 1.
Read More
The newly 510(k) cleared PolySense accessories expand the ZOLL WatchPAT 400 from an HSAT to home PSG.
Read More